Eric Steven BURAK

Person

Dundas, CA

People

Patents Grantslast 30 patents

Information Patent Grant
Residualizing linkers and uses thereof
- Patent number 11,793,895
- Issue date Oct 24, 2023
- Centre for Probe Development and Commercialization
- John Fitzmaurice Valliant
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Actinium-225 and checkpoint inhibitor combination therapy
- Patent number 11,446,401
- Issue date Sep 20, 2022
- Fusion Pharmaceuticals Inc.
- Eric Steven Burak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
IGF-1R monoclonal antibodies and uses thereof
- Patent number 11,433,148
- Issue date Sep 6, 2022
- Centre for Probe Development and Commercialization
- Eric Steven Burak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmacokinetic enhancements of bifunctional chelates and uses thereof
- Patent number 11,191,854
- Issue date Dec 7, 2021
- Centre for Probe Development and Commercialization
- Eric Steven Burak
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Residualizing linkers and uses thereof
- Patent number 10,758,636
- Issue date Sep 1, 2020
- CENTRE FOR PROBE DEVELOPMENT AND COMMERCIALIZATION
- John Fitzmaurice Valliant
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
IGF-1R monoclonal antibodies and uses thereof
- Patent number 10,093,741
- Issue date Oct 9, 2018
- Fusion Pharmaceuticals Inc.
- Eric Steven Burak
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
RADIOIMMUNOCONJUGATES AND CHECKPOINT INHIBITOR COMBINATION THERAPY
- Publication number 20240285818
- Publication date Aug 29, 2024
- Fusion Pharmaceuticals Inc.
- Eric Steven Burak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR TREATMENT OF CANCERS
- Publication number 20240165280
- Publication date May 23, 2024
- Fusion Pharmaceuticals Inc.
- Eric S. Burak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RADIOIMMUNOCONJUGATES AND CHECKPOINT INHIBITOR COMBINATION THERAPY
- Publication number 20230270895
- Publication date Aug 31, 2023
- Fusion Pharmaceuticals Inc.
- Eric Steven Burak
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FGFR3-TARGETED RADIOIMMUNOCONJUGATES AND USES THEREOF
- Publication number 20230201384
- Publication date Jun 29, 2023
- Fusion Pharmaceuticals Inc.
- Eric Steven Burak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUSTAINED IMMUNOTHERAPY
- Publication number 20230091468
- Publication date Mar 23, 2023
- Fusion Pharmaceuticals Inc.
- Eric Steven Burak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IGF-1R MONOCLONAL ANTIBODIES AND USES THEREOF
- Publication number 20230052140
- Publication date Feb 16, 2023
- CENTRE FOR PROBE DEVELOPMENT AND COMMERCIALIZATION
- Eric Steven Burak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RADIOIMMUNOCONJUGATES AND CHECKPOINT INHIBITOR COMBINATION THERAPY
- Publication number 20220088230
- Publication date Mar 24, 2022
- Eric Steven BURAK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RADIOIMMUNOCONJUGATES AND DNA DAMAGE AND REPAIR INHIBITOR COMBINATI...
- Publication number 20220088231
- Publication date Mar 24, 2022
- Eric Steven BURAK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MACROCYCLIC CHELATES AND USES THEREOF
- Publication number 20210395281
- Publication date Dec 23, 2021
- Fusion Pharmaceuticals Inc.
- Stuart J. Mahoney
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RADIOIMMUNOCONJUGATES AND DNA DAMAGE AND REPAIR INHIBITOR COMBINATI...
- Publication number 20210290788
- Publication date Sep 23, 2021
- Fusion Pharmaceuticals Inc.
- Eric Steven Burak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RADIOIMMUNOCONJUGATES AND CHECKPOINT INHIBITOR COMBINATION THERAPY
- Publication number 20210290789
- Publication date Sep 23, 2021
- Fusion Pharmaceuticals Inc.
- Eric Steven Burak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RESIDUALIZING LINKERS AND USES THEREOF
- Publication number 20210060190
- Publication date Mar 4, 2021
- CENTRE FOR PROBE DEVELOPMENT AND COMMERCIALIZATION
- John Fitzmaurice Valliant
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IGF-1R MONOCLONAL ANTIBODIES AND USES THEREOF
- Publication number 20190083662
- Publication date Mar 21, 2019
- Fusion Pharmaceuticals Inc.
- Eric Steven Burak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACOKINETIC ENHANCEMENTS OF BIFUNCTIONAL CHELATES AND USES THEREOF
- Publication number 20190030194
- Publication date Jan 31, 2019
- Fusion Pharmaceuticals Inc.
- Eric Steven Burak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RESIDUALIZING LINKERS AND USES THEREOF
- Publication number 20160279272
- Publication date Sep 29, 2016
- CENTRE FOR PROBE DEVELOPMENT AND COMMERCIALIZATION
- John Fitzmaurice VALLIANT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Eric Steven BURAK

Person

Patents Grantslast 30 patents

Residualizing linkers and uses thereof

Actinium-225 and checkpoint inhibitor combination therapy

IGF-1R monoclonal antibodies and uses thereof

Pharmacokinetic enhancements of bifunctional chelates and uses thereof

Residualizing linkers and uses thereof

IGF-1R monoclonal antibodies and uses thereof

Patents Applicationslast 30 patents

RADIOIMMUNOCONJUGATES AND CHECKPOINT INHIBITOR COMBINATION THERAPY

METHODS FOR TREATMENT OF CANCERS

RADIOIMMUNOCONJUGATES AND CHECKPOINT INHIBITOR COMBINATION THERAPY

FGFR3-TARGETED RADIOIMMUNOCONJUGATES AND USES THEREOF

SUSTAINED IMMUNOTHERAPY

IGF-1R MONOCLONAL ANTIBODIES AND USES THEREOF

RADIOIMMUNOCONJUGATES AND CHECKPOINT INHIBITOR COMBINATION THERAPY

RADIOIMMUNOCONJUGATES AND DNA DAMAGE AND REPAIR INHIBITOR COMBINATI...

MACROCYCLIC CHELATES AND USES THEREOF

RADIOIMMUNOCONJUGATES AND DNA DAMAGE AND REPAIR INHIBITOR COMBINATI...

RADIOIMMUNOCONJUGATES AND CHECKPOINT INHIBITOR COMBINATION THERAPY

RESIDUALIZING LINKERS AND USES THEREOF

IGF-1R MONOCLONAL ANTIBODIES AND USES THEREOF

PHARMACOKINETIC ENHANCEMENTS OF BIFUNCTIONAL CHELATES AND USES THEREOF

RESIDUALIZING LINKERS AND USES THEREOF